The US Court of Appeals for the District of Columbia concluded Novartis AG and United Therapeutics Corporation did not violate the 340B outpatient drug discount program law by imposing restrictions on pharmacies dispensing drugs under contract with hospitals and other health care providers participating in the program.
The decision issued 21 May affirms a lower court decision in favor of the drug companies and against the US...





